Form 8-K - Current report:
SEC Accession No. 0001654954-21-001890
Filing Date
2021-02-19
Accepted
2021-02-19 15:04:49
Documents
17
Period of Report
2021-02-19
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cbmg-20211231.htm   iXBRL 8-K 55091
2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CELLULAR BIOMEDICINE GROUP, cbmg_ex3-1.htm EX-3.1 31662
3 ARTICLES OF INCORPORATION / BYLAWS cbmg_ex3-2.htm EX-3.2 90688
4 PRESS RELEASE DATED FEBRUARY 19, 2021 cbmg_ex99-1.htm EX-99.1 11566
  Complete submission text file 0001654954-21-001890.txt   352289

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cbmg-20211231.xsd EX-101.SCH 3040
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbmg-20211231_cal.xml EX-101.CAL 888
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbmg-20211231_def.xml EX-101.DEF 1887
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbmg-20211231_lab.xml EX-101.LAB 15876
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbmg-20211231_pre.xml EX-101.PRE 11624
10 EXTRACTED XBRL INSTANCE DOCUMENT cbmg-20211231_htm.xml XML 4326
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850 (301) 825 5320
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

EIN.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36498 | Film No.: 21654733
SIC: 2836 Biological Products, (No Diagnostic Substances)